The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of ...
Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...
Exblifep is a combination product that consists of cefepime, a cephalosporin antibacterial, and enmetazobactam, a beta-lactamase inhibitor. The Food and Drug Administration (FDA) has approved Exblifep ...
“UTIs are common infections that are usually contained inside the bladder and do not cause back pain,” notes Barbara Hanna, DO, ob/gyn and co-founder of MyMenopauseRx.com. They happen when bacteria ...
Zaynich, a combination of Zidebactam and Cefepime, has been cleared for the treatment of complicated urinary tract infections ...
Everyday Health on MSN
Complicated urinary tract infections have a new treatment option
Utebzi (tebipenem pivoxil) is a pill, which makes it a more convenient alternative to the intravenous (IV) form of the drug.
Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...
First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...
The FDA has approved GSK’s antibiotic for adults with complicated UTIs, providing an alternative to standard intravenous care ...
Untreated UTIs in pregnancy can progress to kidney infection (pyelonephritis), trigger preterm labour, or contribute to low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results